Key insights
- The author discusses UnitedHealth's significant recovery from its lows, attributing it to market overreaction to temporary issues like the Change Healthcare cyberattack and regulatory fears. Despite potential political risks and valuation concerns, the author believes UNH remains a compelling value play due to its strong business model, growth potential, and shareholder-friendly capital allocation.
I started digging into UnitedHealth when everyone was panicking and it hit $259 earlier this year. The news cycle was brutal, regulatory uncertainty, the Change Healthcare cyberattack mess, political noise around Medicare Advantage. Felt like the perfect storm.
But here's what I kept coming back to: UNH has been through worse. The business model didn't break. They're still the biggest health insurer in the US by a mile, Optum is an absolute cash cow that keeps growing, and the free cash flow generation is ridiculous.
From $259 to $396 is a 53% bounce. That's not just a recovery, that's the market admitting it overreacted. The cyberattack turned out to be a one-off cost hit, not a structural problem. The regulatory fears are still there but haven't materialized into anything concrete.
What makes UNH interesting to me as a value play right now: even after this run, you're paying a reasonable multiple for a business that compounds at 10-15% annually. The dividend has been growing for over a decade. The buyback is active. And healthcare spending isn't exactly going to go down as the population ages.
The bear case is real, political risk around Medicare, potential rate squeeze, and the fact that a lot of the easy money has already been made. But the question is whether UNH at 18-20x earnings is "value" or just "fair."
I'm holding. Curious what others think — is there still upside from here, or is this a 10-bagger decade behind us?